Literature DB >> 2218074

Systemic anaphylaxis--separation of cardiac reactions from respiratory and peripheral vascular events.

S B Felix1, G Baumann, W E Berdel.   

Abstract

An anaphylactic reaction in the isolated perfused heart is characterized by a drastic coronary constriction, arrhythmias, and an impairment of contractility. In vivo anaphylaxis is associated with respiratory distress and cardiovascular failure. The present investigation was designed to ascertain the electrocardiographic and cardiovascular changes during systemic hypersensitivity reactions. In addition, an attempt was made to differentiate cardiac from respiratory events. In guinea pigs, sensitization was produced by s.c. administration of ovalbumin together with Freund's adjuvant solution. Fourteen days after sensitization, the effects of an i.v. infusion of ovalbumin were tested in the anesthetized guinea pigs, which were ventilated with room air or 100% oxygen. A second administration of the antigen induced the development of cardiovascular collapse, leading to death within 12 min. Within 3 min, cardiac output decreased by 90% and end-diastolic left ventricular pressure increased significantly, indicating left ventricular pump failure. In the same time range, ECG recordings uniformly showed signs of acute myocardial ischemia. In addition, arrhythmias occurred in the form of atrioventricular block. Left ventricular contractility declined continuously within the first 4 min. Finally, after 4 min, blood pressure steadily decreased. During ventilation with room air, severe hypoxia developed, with arterial PO2 decreasing from 94 mmHg to 14 mmHg after 3 min. However, under ventilation with 100% oxygen, a dissociation between cardiac damage and respiratory distress occurred. Myocardial ischemia and signs of cardiac failure preceded the development of hypoxia by a significant time interval. It is to be concluded that cardiac damage is a primary event in anaphylactic shock. Furthermore, the electrocardiographic signs of ischemia are interpreted as a result of coronary artery spasm.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2218074     DOI: 10.1007/bf00000029

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  22 in total

1.  The heart seems to be the primary site and the target of anaphylaxis resulting in the development of Kounis syndrome.

Authors:  Nicholas George Kounis; Periklis Davlouros; George Hahalis; Andreas Mazarakis
Journal:  Intern Emerg Med       Date:  2012-04-24       Impact factor: 3.397

2.  Accumulation of eosinophils, mast cells, and basophils in the spleen and the coronary arteries in anaphylactic deaths: is the Kounis hypersensitivity associated syndrome present?

Authors:  Nicholas G Kounis; George D Soufras; George Hahalis
Journal:  Forensic Sci Med Pathol       Date:  2013-10-17       Impact factor: 2.007

3.  Kounis syndrome: a monster for the atopic patient.

Authors:  Nicholas G Kounis
Journal:  Cardiovasc Diagn Ther       Date:  2013-03

4.  Coronary stent thrombosis: beware of an allergic reaction and of Kounis syndrome.

Authors:  Nicholas G Kounis; George D Soufras
Journal:  Indian Heart J       Date:  2013-12-26

5.  Effects of histamine H1-receptor blockade on respiratory and cardiac manifestation of systemic anaphylaxis.

Authors:  S B Felix; G Baumann; T Hashemi; M Niemczyk; G Ochsenfeld; Z Ahmad; S Shirani; H Blömer
Journal:  Agents Actions       Date:  1991-07

6.  Effects of histamine H1- and H2-receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs.

Authors:  S B Felix; G Baumann; M Niemczyk; T Hashemi; G Ochsenfeld; Z Ahmad; S Shirani; H Blömer
Journal:  Agents Actions       Date:  1991-03

7.  Electrocardiographic changes associated with anaphylaxis in a patient with normal coronary arteries.

Authors:  M B Engrav; M Zimmerman
Journal:  West J Med       Date:  1994-12

8.  Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice.

Authors:  Ana Olivera; Christoph Eisner; Yoshiaki Kitamura; Sandra Dillahunt; Laura Allende; Galina Tuymetova; Wendy Watford; Francoise Meylan; Susanne C Diesner; Lingli Li; Jurgen Schnermann; Richard L Proia; Juan Rivera
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

9.  Penicillin allergy in cancer patients manifesting as Kounis syndrome.

Authors:  George D Soufras; Panagiotis V Ginopoulos; Paraskevi J Papadaki; George M Zavras; Georgia V Gouvelou-Deligianni; Maria Batsolaki; Sophia Kouni; Nicholas G Kounis; Constantinos M Koutsojannis
Journal:  Heart Vessels       Date:  2005-07       Impact factor: 2.037

Review 10.  Anaphylactic cardiovascular collapse and Kounis syndrome: systemic vasodilation or coronary vasoconstriction?

Authors:  Nicholas G Kounis; Gianfranco Cervellin; Ioanna Koniari; Laura Bonfanti; Periklis Dousdampanis; Nikolaos Charokopos; Stelios F Assimakopoulos; Stavros K Kakkos; Ioannis G Ntouvas; George D Soufras; Ioannis Tsolakis
Journal:  Ann Transl Med       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.